RetiCap®, represented by CHAPPER healthcare, was named as one of Arab Health’s most innovative top 10 products at this year’s exhibition. The product, which protects the eye from damage caused by diabetes, also attracted media attraction from across the Gulf region.
The easy-to-swallow capsule offers a natural protection and concentrates on the increased need for nutrients for the eye caused by diabetes. It provides preventative support for patients with diabetic retinopathy.
CEO Jonathan Chapper, explains: “It was first time we had showcased RetiCap® in the Middle East and the response received was fantastic. We had an extremely productive four days in Dubai with some great meetings with both new customers and long-established partners.”
Philip Chapper & Company Ltd was established over 40 years ago and has a worldwide reputation for successfully sourcing and distributing pharmaceutical products globally. The company has recently rebranded as CHAPPER healthcare, a change of name that reflects the wider changes taking place across the organisation.
Jonathan added: “The Middle East is one of our key markets and we invest a lot of time and resource into building relationships there. It’s so important for us to come to Arab Health to showcase new products and services and highlight the developments that have taken place within our company over the past year.”
Also on display on the CHAPPER healthcare stand was a range of other products available for exclusive distribution. These included Vitrocap® for vitreous floaters and Macu-Save™, an easy-to-swallow supplement that offers added protection against macular degeneration, the leading cause of severe vision loss in people over 60 as well as other food supplements and medical devices.
CHAPPER healthcare source and distribute products, consolidate orders and organise shipments, to 6 continents worldwide. They supply branded and generic pharmaceuticals including orphan drugs, over the counter medicines, veterinary medicines and other medical supplies.